Base Metals Investing Astria Therapeutics Now Enrolling HAE Patients in the European Union for the Phase 3 ALPHA-ORBIT Trial
Base Metals Investing Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology
Base Metals Investing Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025
Base Metals Investing Astria Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
base metals investing Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
base metals investing Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
base metals investing Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
Standard Uranium Announces Expansion of Davidson River Drill Program and Provides Update on Private Placement and LIFE Offering
